Boron Neutron Capture Therapy (BNCT) is a binary form of cancer therapy which uses a boron-containing compound that preferentially concentrates in tumor sites. The tumor site is then irradiated by a neutron beam. The neutrons in the beam interact with the boron in the tumor to cause the boron atom to split into an alpha particle and lithium nucleus. Both of these particles have a very short range (about one cellular diameter) and cause significant damage to the cell in which it is contained. In this way, damage is done to the tumor cell, while largely sparing healthy tissue.
For general information on BNCT, contact Prof. Otto Harling at (617) 253-4201
For information on
BNCT neutron facilities, contact Peter
at (617) 253-2099 or Kent Riley
at (617) 258-5938
An in depth description of BNCT
| MIT Nuclear Reactor Lab | MIT Home Page |